Orion Corporation, Orion Pharma
Clinical trials sponsored by Orion Corporation, Orion Pharma, explained in plain language.
-
New hope for hard-to-treat cancers? drug combo trial begins
Disease control Recruiting nowThis study tests a new drug called ODM-212 combined with other anti-cancer treatments in people with advanced solid tumors, including mesothelioma, pancreatic cancer, and non-small cell lung cancer. The trial has two parts: first finding a safe dose, then checking how well it wor…
Phase: PHASE1, PHASE2 • Sponsor: Orion Corporation, Orion Pharma • Aim: Disease control
Last updated May 17, 2026 05:31 UTC
-
New hope for Hard-to-Treat cancers: first human trial launches
Disease control Recruiting nowThis study tests a new drug called ODM-212 in people with advanced solid tumours that cannot be cured with current treatments. The trial has two parts: first finding a safe dose, then testing that dose in more patients. About 315 adults with cancers like mesothelioma, lung, or co…
Phase: PHASE1, PHASE2 • Sponsor: Orion Corporation, Orion Pharma • Aim: Disease control
Last updated May 17, 2026 05:07 UTC